Metric Analysis: Zymeworks BC Inc (ZYME)’s Key Ratios in the Limelight

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

In the latest session, Zymeworks BC Inc (NASDAQ: ZYME) closed at $11.74 down -8.64% from its previous closing price of $12.85. In other words, the price has decreased by -$8.64 from its previous closing price. On the day, 0.55 million shares were traded.

Ratios:

For a deeper understanding of Zymeworks BC Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.40 and its Current Ratio is at 3.40. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.

On November 07, 2024, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $10 to $25.

Wells Fargo Downgraded its Overweight to Equal Weight on November 01, 2024, while the target price for the stock was maintained at $12.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 16 ’25 when EcoR1 Capital, LLC bought 73,953 shares for $11.16 per share. The transaction valued at 825,589 led to the insider holds 17,773,727 shares of the business.

EcoR1 Capital, LLC bought 54,760 shares of ZYME for $630,819 on Apr 17 ’25. The Director now owns 17,828,487 shares after completing the transaction at $11.52 per share. On Apr 04 ’25, another insider, EcoR1 Capital, LLC, who serves as the Director of the company, bought 196,438 shares for $11.17 each. As a result, the insider paid 2,193,800 and bolstered with 17,699,774 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 10.79 while its Price-to-Book (P/B) ratio in mrq is 2.41.

Stock Price History:

Over the past 52 weeks, ZYME has reached a high of $17.70, while it has fallen to a 52-week low of $8.21. The 50-Day Moving Average of the stock is -3.30%, while the 200-Day Moving Average is calculated to be -8.98%.

Shares Statistics:

A total of 68.96M shares are outstanding, with a floating share count of 67.30M. Insiders hold about 4.07% of the company’s shares, while institutions hold 97.88% stake in the company.

Most Popular